| Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer (NCT00245050) | Case Comprehensive Cancer Center | 2004-04-01 |
| A Study of the Proper Dosage of Lovastatin and Docetaxel for Patients With Cancer (NCT00584012) | Susan L Roeder | 2004-04-01 |
| Efficacy and Safety of 500mg of Fulvestrant (NCT00585507) | Beth Israel Deaconess Medical Center | 2004-04-01 |
| Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer (NCT00079118) | Alliance for Clinical Trials in Oncology | 2004-04-01 |
| Capecitabine in Treating Patients With Metastatic Breast Cancer (NCT00274768) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2004-04-01 |
| Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast Cancer (NCT00081796) | Sanofi | 2004-04-01 |
| A Study of Gemcitabine and Carboplatin (Plus Herceptin in Human Epidermal Growth Factor Receptor 2 Positive [HER2+] Patients) With Metastatic Breast Cancer (NCT00191451) | Eli Lilly and Company | 2004-04-01 |
| Study of Faslodex +/- Concomitant Arimidex v Exemestane Following Progression on Non-steroidal Aromatase Inhibitors (NCT00253422) | Institute of Cancer Research, United Kingdom | 2004-03-26 |
| Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease (NCT00080756) | City of Hope Medical Center | 2004-03-11 |
| Gemcitabine + Carboplatin in Breast Cancer (NCT00450762) | Ludwig-Maximilians - University of Munich | 2004-03-01 |
| HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer. (NCT00412022) | National Cancer Institute, Naples | 2004-03-01 |
| Evaluation of Accelerated Partial Breast Brachytherapy (NCT00593346) | Washington University School of Medicine | 2004-03-01 |
| The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer (NCT00171314) | Novartis Pharmaceuticals | 2004-03-01 |
| To Evaluate the Efficacy and Safety of Capecitabine Prior to Surgery in Women With Breast Cancer (NCT02846428) | Hoffmann-La Roche | 2004-03-01 |
| Genistein in Preventing Breast or Endometrial Cancer in Healthy Postmenopausal Women (NCT00099008) | UNC Lineberger Comprehensive Cancer Center | 2004-03-01 |
| Gene Expression Following Short Term Exposure to Neoadjuvant Endocrine Therapy in Invasive Breast Cancer (NCT00588003) | Memorial Sloan Kettering Cancer Center | 2004-03-01 |
| High-Dose Esterified Estrogens in Treating Postmenopausal Women With Metastatic Breast Cancer That Has Failed Previous Hormone Therapy (NCT00131924) | Northwestern University | 2004-03-01 |
| Frequency of Portal Images Required to Enhance Quality Assurance for Breast Cancer Patients Treated With Radiotherapy (NCT00123812) | AHS Cancer Control Alberta | 2004-03-01 |
| Cavilon Breast Trial: Comparison of Cavilon Durable Barrier Cream to Glycerine ("Sorbolene") Cream (NCT00193908) | Trans Tasman Radiation Oncology Group | 2004-03-01 |
| Internet-based System for Cancer Patients to Self-report Toxicity (NCT00578006) | Memorial Sloan Kettering Cancer Center | 2004-03-01 |
| GW572016 and Trastuzumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2/Neu (NCT00085020) | Jonsson Comprehensive Cancer Center | 2004-03-01 |
| Capecitabine (XELODA) With Or Without Lapatinib (GW572016) For Women With Refractory Advanced or Metastatic Breast Cancer (NCT00078572) | GlaxoSmithKline | 2004-03-01 |
| Docetaxel Followed by Doxorubicin Plus Cyclophosphamide for Node Positive or High-Risk Primary Breast Cancer (NCT00193115) | SCRI Development Innovations, LLC | 2004-03-01 |
| Ultrasound and Chemotherapy of Breast Cancer: Relationship Between Early Vascular Changes of the Tumor and Late Tumoral Response (NCT00245869) | University Hospital, Tours | 2004-03-01 |
| Secondary Adjuvant Long Term Study With Arimidex (NCT00295620) | AstraZeneca | 2004-03-01 |
| A Study of CDX-1307, in Patients With Incurable Breast, Colorectal, Pancreatic, Ovarian or Bladder Cancer (CDX 1307-01) (NCT00709462) | Celldex Therapeutics | 2004-03-01 |
| Novel Epothilone (BMS-247550) in Patients With Metastatic Breast Cancer (MBC) (NCT00080262) | R-Pharm | 2004-02-01 |
| Accelerated Partial Breast Radiotherapy With Either Mammosite or Intensity Modulated Radiotherapy (NCT01185145) | Rocky Mountain Cancer Centers | 2004-02-01 |
| A Study of ZD1839 Effects on Cell Proliferation in Breast Cancer (NCT00252811) | AstraZeneca | 2004-02-01 |
| Vaccine Plus Montanide ISA-51 and Sargramostim in Treating Patients With Stage IV Breast Cancer (NCT00079157) | Abramson Cancer Center at Penn Medicine | 2004-02-01 |
| Gemcitabine Hydrochloride and Genistein in Treating Women With Stage IV Breast Cancer (NCT00244933) | Barbara Ann Karmanos Cancer Institute | 2004-02-01 |
| Dose Escalation Trial of 2-Deoxy-D-Glucose (2DG) in Subjects With Advanced Solid Tumors (NCT00096707) | Threshold Pharmaceuticals | 2004-02-01 |
| EC Followed Docetaxel Versus ET Followed Capecitabine as Adjuvant Chemotherapy for Node Positive Operable Breast Cancer (NCT00129935) | Spanish Breast Cancer Research Group | 2004-02-01 |
| Melatonin Postoperative Sleep Study in Breast Cancer Patients (NCT00506064) | M.D. Anderson Cancer Center | 2004-02-01 |
| Randomized Controlled Phase II Trial of Pre-operative Celecoxib Treatment in Breast Cancer (NCT01695226) | Maastricht University Medical Center | 2004-02-01 |
| Docetaxel Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer (NCT00343512) | Vanderbilt-Ingram Cancer Center | 2004-02-01 |
| Sentinel Lymph Node Biopsy and Primary Tumor Gene Expression Profiling in Finding Axillary Lymph Node Metastases in Women Who Have Received Neoadjuvant Therapy for Stage II, Stage III, or Stage IV Breast Cancer (NCT00080860) | National Institutes of Health Clinical Center (CC) | 2004-02-01 |
| BREAST-10: Three-weekly Versus Weekly First-line Chemotherapy for Metastatic or Locally Advanced Breast Cancer (NCT00540800) | National Cancer Institute, Naples | 2004-02-01 |
| Adjuvant Chemotherapy With Epirubicin, CMF, and Weekly Docetaxel or Weekly Paclitaxel in Patients With Resected High-risk Breast Cancer (NCT04829890) | Hellenic Cooperative Oncology Group | 2004-02-01 |
| Does Scar Massage Improve Postoperative Pain and Function in Women With Breast Cancer? (NCT00175344) | University of British Columbia | 2004-02-01 |
| Whole Brain Radiation Therapy With Oxygen, With or Without RSR13, in Women With Brain Metastases From Breast Cancer (NCT00083304) | Spectrum Pharmaceuticals, Inc | 2004-02-01 |
| Frequency Domain Optical Imaging (NCT05246735) | Dartmouth-Hitchcock Medical Center | 2004-02-01 |
| BAY43-9006 - Phase II in Advanced Breast Cancer (NCT00101400) | Bayer | 2004-02-01 |
| Administration of Ketamine to Prevent the Post-operative Pain (NCT00210210) | Institut Bergonié | 2004-01-31 |
| Collecting and Storing Tissue Samples From Women With or Without Breast Cancer (NCT00899301) | Vanderbilt-Ingram Cancer Center | 2004-01-22 |
| Eligibility Screening for the NIH Intramural Research Program Clinical Protocols (NCT00026754) | National Cancer Institute (NCI) | 2004-01-14 |
| Relationship of pAKT to Survival in Patients With Node-Positive Breast Cancer (NCT00965276) | National Cancer Institute (NCI) | 2004-01-13 |
| Gefitinib With or Without Tamoxifen in Treating Patients With Tamoxifen-Resistant Metastatic Breast Cancer (NCT00080743) | Dartmouth-Hitchcock Medical Center | 2004-01-01 |
| Neoadjuvant Chemotherapy With Myocet/Taxotere/Herceptin for HER2 Positive Breast Cancer Patients (NCT00129896) | Spanish Breast Cancer Research Group | 2004-01-01 |
| Design and Feasibility of a Mediterranean Diet (NCT00120016) | University of Michigan | 2004-01-01 |
| Radiofrequency of Breast Cancers in Non Surgical Patients (NCT00210223) | Institut Bergonié | 2004-01-01 |
| NAC Sparing Mastectomy After Neo-adjuvant Chemotherapy (NCT02471742) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2004-01-01 |
| Docetaxel Followed by CEF (Cyclophosphamide, Epirubicin and 5-Fluorouracil) Compared to Docetaxel and Capecitabine Followed by CEX (Cyclophosphamide, Epirubicin and Capecitabine) as Adjuvant Treatment for Breast Cancer (NCT00114816) | Finnish Breast Cancer Group | 2004-01-01 |
| Yoga in Controlling Symptoms and Reducing Stress in Women With Ovarian Cancer or Breast Cancer (NCT00337233) | Wake Forest University Health Sciences | 2004-01-01 |
| Neoadjuvant/Adjuvant Chemotherapy, Vaccine & Adjuvant Radiation Therapy in p53-Overexpressing Stage III Breast Cancer (NCT00082641) | University of Nebraska | 2004-01-01 |
| Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Women With Locally Recurrent or Metastatic Breast Cancer (NCT00088985) | UNC Lineberger Comprehensive Cancer Center | 2004-01-01 |
| Dietary Fat, Eicosanoids and Breast Cancer Risk (NCT01824498) | USDA Grand Forks Human Nutrition Research Center | 2004-01-01 |
| Adjuvant Oophorectomy and Tamoxifen in Premenopausal Women With Hormone Receptor-Positive Breast Cancer (NCT00201851) | International Breast Cancer Research Foundation | 2004-01-01 |
| Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination Therapy (NCT00256698) | AstraZeneca | 2004-01-01 |
| Psychotherapy to Patients With Primary Breast Cancer - Psycho-social and Survival Outcome From a Randomised Trial (NCT01108224) | Danish Cancer Society | 2004-01-01 |
| Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer (NCT00086957) | City of Hope Medical Center | 2004-01-01 |
| Anastrozole in Treating Postmenopausal Women With DCIS or Stage I-III Breast Cancer (NCT00244959) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2004-01-01 |
| Docetaxel Plus Garlic in Treating Patients With Locally Advanced or Metastatic Breast Cancer (NCT00079170) | National Cancer Institute (NCI) | 2004-01-01 |
| Peer Counseling for Weight Loss (NCT00120029) | Wayne State University | 2004-01-01 |
| Combination Chemotherapy With or Without Darbepoetin Alfa in Treating Women With Stage III Breast Cancer (NCT00309920) | Heinrich-Heine University, Duesseldorf | 2004-01-01 |
| Vaccine Therapy With or Without Cyclophosphamide and Doxorubicin in Women With Stage IV Breast Cancer (NCT00093834) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2004-01-01 |
| Reducing Underuse of Early-Stage Breast Cancer Treatment in Minority Communities (NCT00145197) | Icahn School of Medicine at Mount Sinai | 2004-01-01 |
| Comparing Anastrozole-Placebo to the Combination Anastrozole-ZD1839 in Postmenopausal Patients With Estrogen Receptor and/or Progesterone Receptor Metastatic Breast Cancer (NCT00077025) | AstraZeneca | 2004-01-01 |
| Letrozole and Celecoxib in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer (NCT00101062) | University of Medicine and Dentistry of New Jersey | 2004-01-01 |
| Phase II Neoadjuvant ER+/PgR + Arimidex +/- Iressa Study (NCT00255463) | AstraZeneca | 2004-01-01 |
| Collection of Tissue Samples for Study of Multidrug Resistance (NCT00880503) | National Cancer Institute (NCI) | 2003-12-19 |
| Preoperative Herceptin/Navelbine Versus Taxotere/Carboplatin/Herceptin in HER-2 Positive Breast Cancer (NCT00148668) | Eric Winer, MD | 2003-12-01 |
| Effects of Exercise Intervention on Insulin Levels in Breast Cancer Survivors (NCT00153894) | Dana-Farber Cancer Institute | 2003-12-01 |
| Exercise and Dietary Counseling in Improving Physical Activity, Nutrition, and Quality of Life in Older Long-Term Cancer Survivors Who Are Overweight (NCT00303875) | Duke University | 2003-12-01 |
| Study With Docetaxel, Carboplatin and Herceptin Versus Vinorelbine and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients (NCT00453635) | Hellenic Oncology Research Group | 2003-12-01 |
| Prone Breast Irradiation for Pendulous Breasts (NCT00181363) | Maastricht Radiation Oncology | 2003-12-01 |
| Anastrozole Plus Lonafarnib (SCH 66336) or Plus Placebo for the Treatment of Advanced Breast Cancer (P03480) (NCT00081510) | Merck Sharp & Dohme LLC | 2003-12-01 |
| Phase II Study of Tetrathiomolybdate (TM) in Patients With Breast Cancer (NCT00195091) | Memorial Sloan Kettering Cancer Center | 2003-12-01 |
| Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy (NCT00195013) | Weill Medical College of Cornell University | 2003-12-01 |
| Pain Management Following TRAM Flap for Breast Reconstruction (NCT00500565) | M.D. Anderson Cancer Center | 2003-12-01 |
| Docetaxel and Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Breast Cancer (NCT00080665) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2003-12-01 |
| Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer (NCT00066443) | NCIC Clinical Trials Group | 2003-11-03 |
| Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer (NCT00066703) | ETOP IBCSG Partners Foundation | 2003-11-03 |
| Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer (NCT00082433) | R-Pharm | 2003-11-01 |
| Ph II Letrozole + OSI-774 (Tarceva) in Post-menopausal, w/ ER and/or PR-positive Met Breast Cancer. (NCT00611715) | Vanderbilt-Ingram Cancer Center | 2003-11-01 |
| Nipple Aspiration, Ductal Lavage, and Duct Endoscopy in Screening Women at Moderate-to-High Risk of Developing Breast Cancer (NCT00081003) | Royal Marsden NHS Foundation Trust | 2003-11-01 |
| Combination Gemcitabine, Carboplatin With or Without Trastuzumab in Patients With Metastatic Breast Cancer (NCT00193076) | SCRI Development Innovations, LLC | 2003-11-01 |
| Adjuvant Hypofractionated Intensity-Modulated Radiation Therapy With Incorporated Boost in Treating Patients With Early-Stage Breast Cancer (NCT00084539) | Fox Chase Cancer Center | 2003-11-01 |
| Evaluation of Patients With Breast Cancer Using DCE-MRI, MRS, and Proteomics (NCT00656604) | Vanderbilt-Ingram Cancer Center | 2003-11-01 |
| S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer (NCT00070564) | SWOG Cancer Research Network | 2003-11-01 |
| Vinorelbine and Celecoxib in Treating Women With Relapsed or Metastatic Breast Cancer (NCT00075673) | Case Comprehensive Cancer Center | 2003-11-01 |
| S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer (NCT00068601) | SWOG Cancer Research Network | 2003-10-01 |
| Neoadjuvant Letrozole in Treating Postmenopausal Women With Estrogen-Receptor Positive and/or Progesterone-Receptor Positive Stage II, Stage IIIA, or Stage IIIB Breast Cancer (NCT00084396) | Washington University School of Medicine | 2003-10-01 |
| Duct Endoscopy in Assessing Cellular Atypia in the Breast Duct Fluid of Women With a Genetic Risk for Breast Cancer (NCT00082979) | Royal Marsden NHS Foundation Trust | 2003-10-01 |
| Arm Function and Quality of Life Following Mastectomy. (NCT00379106) | University of New Mexico | 2003-10-01 |
| Socio-aesthetic Intervention on Body Image and Quality of Life in Women With Breast Cancer. (NCT00210145) | Institut Bergonié | 2003-10-01 |
| A Pharmacogenomics Study for Breast Cancer Patients Undergoing Adjuvant Chemotherapy With Doxorubicin (A)/Cyclophosphamide ©) and/or Weekly Paclitaxel (NCT00131963) | Duke University | 2003-10-01 |
| Ductal Lavage in Assessing Women With Early Breast Cancer or at High Risk of Developing Breast Cancer and Who Are Eligible For Tamoxifen Therapy (NCT00083044) | Northwestern University | 2003-10-01 |
| Accelerated Radiotherapy Outcomes in Women (NCT00156130) | Ontario Clinical Oncology Group (OCOG) | 2003-10-01 |
| Secondary Adjuvant Treatment for Patients With Isolated Tumor Cells in Bone Marrow (NCT00248703) | Oslo University Hospital | 2003-10-01 |